We try to allow early access to our medicines when they look promising. PharmaMar has deployed compassionate use programs in many countries to enable early access, to patients with severe conditions and limited options. For example, our current compassionate use program has enrolled over 2500 patients from many countries.
Find out if such a program exists in your location by requesting information from us on compassionate use programs; email either email@example.com for oncology or firstname.lastname@example.org for virology, stating your interest and country of residence. The enquiry must come from a healthcare professional using their institutional email address.